GL1X · GenesisL1 explorer

Research workbench

Plla lectin, monosaccharide complex

Analyse Plla lectin, monosaccharide complex in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5ODU
Type
protein
Length
968 residues
Chains
8
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Plla
UniProt
Q7N561
Ligands
AMG, CA
Pockets
6 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 2% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, D, E, F, G, HPllaprotein1212% helix, 50% strandQ7N561

Ligands and binding sites

  • AMG · methyl alpha-D-galactopyranoside · ligand · 8 copies · chains A, B, C, D, E, F, G, H
  • CA · Calcium ion · metal · 8 copies · chains A, B, C, D, E, F, G, H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13410.560.7644empty
21680.480.7727empty
3500.390.8012empty
4750.370.7818empty
51020.350.7417empty

Interfaces

10 interfaces between chains.

  • D–H · 1056 Ų buried · 16 hydrogen bonds · protein-protein
  • F–G · 1048 Ų buried · 16 hydrogen bonds · protein-protein
  • A–C · 1034 Ų buried · 16 hydrogen bonds · protein-protein
  • B–H · 756 Ų buried · 7 hydrogen bonds · protein-protein
  • C–E · 299 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 5ODU · PllA lectin, monosaccharide complex · the same entry in another collection · chain H against H, TM-score 1.00
  • Q7N561 · AlphaFold monomer V2.0 prediction for lectin a (Q7N561) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.